AbCellera Biologics Inc. - Ordinary Shares (ABCL)

Historical Holders from Q4 2020 to Q2 2025

Symbol
ABCL on Nasdaq
CUSIP
00288U106
Type / Class
Equity / Ordinary Shares
Shares outstanding
293M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
108M
Holdings value
$371M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
127
Number of buys
54
Number of sells
-63
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AbCellera Biologics Inc. - Ordinary Shares (ABCL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAILLIE GIFFORD & CO 4.4% $30.9M 12.9M BAILLIE GIFFORD & CO Sep 30, 2024

Institutional Holders of AbCellera Biologics Inc. - Ordinary Shares (ABCL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 108M $371M -$42.1M $3.43 127
2025 Q1 125M $279M +$21.8M $2.23 127
2024 Q4 114M $334M +$26.6M $2.93 145
2024 Q3 105M $272M -$30.3M $2.60 138
2024 Q2 114M $338M -$10.3M $2.96 146
2024 Q1 120M $542M +$1.05M $4.53 152
2023 Q4 10.9M $62.4M -$154K $5.71 3
2023 Q3 119M $547M -$26.5M $4.60 135
2023 Q2 123M $795M -$50.6M $6.46 163
2023 Q1 130M $980M +$10.2M $7.54 180
2022 Q4 128M $1.3B +$62.1M $10.13 195
2022 Q3 117M $1.16B +$9.43M $9.89 179
2022 Q2 118M $1.26B +$149M $10.65 157
2022 Q1 113M $1.1B -$3.87M $9.75 123
2021 Q4 113M $1.6B +$96.1M $14.30 117
2021 Q3 96.9M $1.94B +$137M $20.04 112
2021 Q2 89.7M $1.97B +$163M $22.00 108
2021 Q1 70.6M $2.4B +$66M $33.96 82
2020 Q4 68.1M $2.74B +$2.59B $40.24 58